Current Ratio in % of Clearside Biomedical, Inc. from Q1 2017 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Clearside Biomedical, Inc. quarterly Current Ratio history and change rate from Q1 2017 to Q3 2025.
Clearside Biomedical, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 367 %, a 26.7% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

Clearside Biomedical, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	367	-133	-26.7%	30 Sep 2025
Q2 2025	402	-116	-22.4%	30 Jun 2025
Q1 2025	433	-125	-22.4%	31 Mar 2025
Q4 2024	505	-104	-17.1%	31 Dec 2024
Q3 2024	500	-226	-31.2%	30 Sep 2024
Q2 2024	518	-343	-39.8%	30 Jun 2024
Q1 2024	558	-270	-32.6%	31 Mar 2024
Q4 2023	610	-216	-26.2%	31 Dec 2023
Q3 2023	726	-110	-13.2%	30 Sep 2023
Q2 2023	861	+287	+50.1%	30 Jun 2023
Q1 2023	828	+336	+68.2%	31 Mar 2023
Q4 2022	826	+451	+121%	31 Dec 2022
Q3 2022	837	+578	+223%	30 Sep 2022
Q2 2022	574	+336	+141%	30 Jun 2022
Q1 2022	492	+287	+140%	31 Mar 2022
Q4 2021	374	+194	+108%	31 Dec 2021
Q3 2021	259	+66.6	+34.6%	30 Sep 2021
Q2 2021	238	+38.3	+19.2%	30 Jun 2021
Q1 2021	205	-26.4	-11.4%	31 Mar 2021
Q4 2020	180	-92.1	-33.9%	31 Dec 2020
Q3 2020	193	-125	-39.4%	30 Sep 2020
Q2 2020	199	-188	-48.6%	30 Jun 2020
Q1 2020	231	-256	-52.5%	31 Mar 2020
Q4 2019	272	-329	-54.8%	31 Dec 2019
Q3 2019	318	-241	-43.2%	30 Sep 2019
Q2 2019	387	-178	-31.5%	30 Jun 2019
Q1 2019	487	-82.4	-14.5%	31 Mar 2019
Q4 2018	601	-6.66	-1.1%	31 Dec 2018
Q3 2018	559	-348	-38.4%	30 Sep 2018
Q2 2018	565	-712	-55.7%	30 Jun 2018
Q1 2018	569	-682	-54.5%	31 Mar 2018
Q4 2017	607			31 Dec 2017
Q3 2017	908			30 Sep 2017
Q2 2017	1.28K			30 Jun 2017
Q1 2017	1.25K			31 Mar 2017

* An asterisk sign (*) next to the value indicates that the value is likely invalid.